Skip to Main Content

Author Details

Lubbertus C F Mulder
Icahn School of Medicine at Mount Sinai
1993
38
21
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35333911ISG15 deficiency restricts HIV-1 infection.PLoS Pathog2022
35784650Development of an HIV reporter virus that identifies latently infected CD4<sup>+</sup> T cells.Cell Rep Methods2022
33691060Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.N Engl J Med2021
33501468The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera.medRxiv2021
31801862Impact of Suboptimal APOBEC3G Neutralization on the Emergence of HIV Drug Resistance in Humanized Mice.J Virol2020
32053707HIV protease cleaves the antiviral m6A reader protein YTHDF3 in the viral particle.PLoS Pathog2020
30257946IL-15 regulates susceptibility of CD4<sup>+</sup> T cells to HIV infection.Proc Natl Acad Sci U S A2018
28605635Expression of HERV-K108 envelope interferes with HIV-1 production.Virology2017
28346446Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection.Nat Microbiol2017
29046457HIV-1 Infection of Primary CD4<sup>+</sup> T Cells Regulates the Expression of Specific Human Endogenous Retrovirus HERV-K (HML-2) Elements.J Virol2017
26789921Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection.Immunity2016
26962222Comparative Analysis of HIV-1 and Murine Leukemia Virus Three-Dimensional Nuclear Distributions.J Virol2016
26651948Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding.Cell Host Microbe2015
24648457HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.J Virol2014
25142601Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.J Virol2014
24586659Positive regulation of TRAF6-dependent innate immune responses by protein phosphatase PP1-γ.PLoS One2014
23555265Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling.PLoS Pathog2013
23593015Balancing selection on a regulatory region exhibiting ancient variation that predates human-neandertal divergence.PLoS Genet2013
23055924DENV inhibits type I IFN production in infected cells by cleaving human STING.PLoS Pathog2012
22174685SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection.PLoS Pathog2011
20592068Moderate influence of human APOBEC3F on HIV-1 replication in primary lymphocytes.J Virol2010
18945781Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H.J Virol2009
18391217Cytidine deamination induced HIV-1 drug resistance.Proc Natl Acad Sci U S A2008
17109911Characterization of HIV-1 integrase N-terminal mutant viruses.Virology2007
16710452Effect of DNA repair protein Rad18 on viral infection.PLoS Pathog2006
16055722A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons.Mol Cell Biol2005
12016221Interaction of HIV-1 integrase with DNA repair protein hRad18.J Biol Chem2002
11781829Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes.Oncogene2001
11032369An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors.Transgenic Res2000
10893419Degradation of HIV-1 integrase by the N-end rule pathway.J Biol Chem2000
9971830CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function.J Virol1999
9507885Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection.J Urol1998
9047349Human CD46 aberrant splicing in transgenic mice.Gene1997
8623287Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model.Transplant Proc1996
8991289Do macrophages kill through apoptosis?Immunol Today1996
8644143Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.Transplant Proc1996
7533403Mice transgenic for human CD46 and CD55 are protected from human complement attack.Transplant Proc1995
8043307Preimplantation embryo sexing by polymerase chain reaction amplification of the sry gene on single mouse blastomeres.Genet Anal Tech Appl1993
  • 1 - 38 of 38

Recommended Authors

VA-MD Regional College of Veterinary Medicine, Virginia Tech
Career Start Year 2009
Number of shared co-authors 5
The Institute of Medical Science, The University of Tokyo
Career Start Year 2008
Number of shared co-authors 1
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 4
Graduate School of Medicine, Kyoto University
Career Start Year 2004
Number of shared co-authors 2
Minnesota Supercomputing Institute, University of Minnesota
Career Start Year 2003
Number of shared co-authors 3
Leidos Biomedical Research Inc.
Career Start Year 2003
Number of shared co-authors 1
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 1
MRC - University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 1998
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1996
Number of shared co-authors 5
University College London
Career Start Year 1995
Number of shared co-authors 9
University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 10
University of California Berkeley
Career Start Year 1993
Number of shared co-authors 5
Inc., Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 2
University of California los angeles
Career Start Year 1992
Number of shared co-authors 12
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 2
University of Utah
Career Start Year 1991
Number of shared co-authors 7
Altius Institute for Biomedical Sciences
Career Start Year 1990
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 9
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 2
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 17
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 12
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 10
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 6
University of California at San Francisco
Career Start Year 1978
Number of shared co-authors 5
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 1
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 1
Columbia University
Career Start Year 1973
Number of shared co-authors 11
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 4
Gladstone Institute of Virology, USA University of California san francisco
Career Start Year 1971
Number of shared co-authors 5

Collaborators

Icahn School of Medicine at Mount Sinai
Co-authored papers 21
Icahn School of Medicine at Mount Sinai
Co-authored papers 9
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Co-authored papers 6
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Paul-Ehrlich-Institut
Co-authored papers 3
Icahn School of Medicine at Mount Sinaigrid.59734.3c
Co-authored papers 3
Indian Institute of Science
Co-authored papers 3
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
The Scripps Research Institute
Co-authored papers 2
University of California irvine
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
University of California berkeley
Co-authored papers 1
Emory University School of Medicine
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Roche Pharma Research and Early Development
Co-authored papers 1
College of Veterinary Medicine, Kansas State University
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
College of Veterinary Medicine, Oregon State University
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1
Carlson College of Veterinary Medicine, Oregon State University
Co-authored papers 1
Duke University School of Medicine
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Gladstone Institutes
Co-authored papers 1
Albert Einstein College of Medicine
Co-authored papers 1
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 1